FDA: Oral Contraceptives and Increased Risk for Blood Clots
The U.S. Food and Drug Administration announced Monday a “continued concern” regarding the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. The FDA conducted a study which suggests there is an approximately 1.5-fold increase in the risk of blood clots for women who use drospirenone-containing birth control pills compared to users of other hormonal contraceptives. Some common names of these types of contraceptives include: Yaz, Yasmin, and Ocella.
Bayer Corporation manufactures Yaz, Yasmin, and Ocella and has marketed this product as a safe and effective oral contraceptive. However, studies have shown that drospirenone-containing birth control pills have been linked to an increase in potassium levels in the blood which can cause heart rhythm disturbances that could lead to blood clots and/or stroke, and can be fatal if left untreated. Drospirenone can also cause gall bladder disease and kidney stone formation, which can require surgery.
Cohen & Malad, LLP currently represents many women across the country who have sustained devastating and life threatening injuries as a result of ingesting Yaz, Yasmin, or Ocella. If you or a loved one has suffered as a result of the use of Yaz, Yasmin, or Ocella, please contact our office today to speak with one of our product liability/personal injury attorneys to discuss your legal options.
